G. Chabanon

1.5k total citations
49 papers, 1.1k citations indexed

About

G. Chabanon is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Plant Science. According to data from OpenAlex, G. Chabanon has authored 49 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 13 papers in Pulmonary and Respiratory Medicine and 11 papers in Plant Science. Recurrent topics in G. Chabanon's work include Cystic Fibrosis Research Advances (13 papers), Plant Pathogenic Bacteria Studies (10 papers) and Antibiotic Resistance in Bacteria (10 papers). G. Chabanon is often cited by papers focused on Cystic Fibrosis Research Advances (13 papers), Plant Pathogenic Bacteria Studies (10 papers) and Antibiotic Resistance in Bacteria (10 papers). G. Chabanon collaborates with scholars based in France, United States and Mexico. G. Chabanon's co-authors include Christine Segonds, N. Marty, Patrice Nordmann, Claire Héritier, Laurent Poirel, Thierry Heulin, M. Archambaud, Sylvie Saivin, Georges Houin and Jean‐Marie Conil and has published in prestigious journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and Critical Care Medicine.

In The Last Decade

G. Chabanon

46 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Chabanon France 19 408 335 261 245 244 49 1.1k
E. Platsouka Greece 16 475 1.2× 204 0.6× 256 1.0× 184 0.8× 180 0.7× 33 906
T.G. Winstanley United Kingdom 13 357 0.9× 144 0.4× 392 1.5× 159 0.6× 192 0.8× 27 1.2k
María García-Castillo Spain 22 842 2.1× 274 0.8× 322 1.2× 314 1.3× 291 1.2× 40 1.2k
P. Y. Chau Hong Kong 20 343 0.8× 234 0.7× 462 1.8× 213 0.9× 142 0.6× 68 1.3k
E. Yourassowsky Belgium 16 300 0.7× 171 0.5× 334 1.3× 287 1.2× 196 0.8× 170 1.2k
Peter Taylor Australia 12 214 0.5× 223 0.7× 121 0.5× 46 0.2× 191 0.8× 25 740
Catherine Neuwirth France 25 1.2k 3.0× 808 2.4× 360 1.4× 228 0.9× 500 2.0× 73 2.0k
Doroti de Oliveira Garcia Brazil 16 656 1.6× 293 0.9× 228 0.9× 169 0.7× 212 0.9× 37 917
Pitak Santanirand Thailand 21 393 1.0× 182 0.5× 464 1.8× 105 0.4× 270 1.1× 79 1.2k
Sophie Vimont France 16 815 2.0× 638 1.9× 477 1.8× 130 0.5× 237 1.0× 32 1.5k

Countries citing papers authored by G. Chabanon

Since Specialization
Citations

This map shows the geographic impact of G. Chabanon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Chabanon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Chabanon more than expected).

Fields of papers citing papers by G. Chabanon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Chabanon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Chabanon. The network helps show where G. Chabanon may publish in the future.

Co-authorship network of co-authors of G. Chabanon

This figure shows the co-authorship network connecting the top 25 collaborators of G. Chabanon. A scholar is included among the top collaborators of G. Chabanon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Chabanon. G. Chabanon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Segonds, Christine, Michelle Thouverez, Antoine Barthe, et al.. (2014). Development of a Multiple-Locus Variable-Number Tandem-Repeat Typing Scheme for Genetic Fingerprinting of Burkholderia cenocepacia and Application to Nationwide Epidemiological Analysis. Journal of Clinical Microbiology. 53(2). 398–409. 5 indexed citations
2.
Segonds, Christine, Michelle Thouverez, Dominique Grenet, Patrick Plésiat, & G. Chabanon. (2009). Microbiological and epidemiological features of clinical respiratory isolates of Burkholderia gladioli. Journal of Cystic Fibrosis. 8. S35–S35. 2 indexed citations
3.
Conil, Jean‐Marie, B. Georges, Michel Lavit, et al.. (2007). Pharmacokinetics of ceftazidime and cefepime in burn patients: the importance of age and creatinine clearance. International Journal of Clinical Pharmacology and Therapeutics. 45(10). 529–538. 36 indexed citations
4.
Santos, Paulina Estrada‐de los, Christine Segonds, Jesús Caballero-Mellado, et al.. (2007). Selection of nitrogen‐fixing deficient Burkholderia vietnamiensis strains by cystic fibrosis patients: involvement of nif gene deletions and auxotrophic mutations. Environmental Microbiology. 9(5). 1176–1185. 22 indexed citations
5.
Georges, B., Jean‐Marie Conil, P. Cougot, et al.. (2005). Cefepime in critically ill patients: continuous infusion vs. an intermittent dosing regimen. International Journal of Clinical Pharmacology and Therapeutics. 43(8). 360–369. 70 indexed citations
6.
Poirel, Laurent, et al.. (2004). OXA-58, a Novel Class D β-Lactamase Involved in Resistance to Carbapenems inAcinetobacter baumannii. Antimicrobial Agents and Chemotherapy. 49(1). 202–208. 235 indexed citations
7.
Dubouix, Anne, É. Bonnet, M. Archambaud, et al.. (2004). Bacillus cereus infections in Traumatology–Orthopaedics Department: retrospective investigation and improvement of healthcare practices. Journal of Infection. 50(1). 22–30. 33 indexed citations
8.
Georges, B., M. Archambaud, P. Cougot, et al.. (2002). Intérêt de l'association cefpirome-vancomycine sur la cinétique de bactéricidie dans les infections sévères à SAMR en réanimation. Pathologie Biologie. 50(3). 161–168. 2 indexed citations
9.
Georges, B., M. Archambaud, Sylvie Saivin, et al.. (1999). [Continuous versus intermittent cefepime infusion in critical care. Preliminary results].. PubMed. 47(5). 483–5. 15 indexed citations
10.
Segonds, Christine, Thierry Heulin, N. Marty, & G. Chabanon. (1999). Differentiation of Burkholderia Species by PCR-Restriction Fragment Length Polymorphism Analysis of the 16S rRNA Gene and Application to Cystic Fibrosis Isolates. Journal of Clinical Microbiology. 37(7). 2201–2208. 123 indexed citations
11.
Henry, Stanley C., et al.. (1998). [Direct diagnosis of Chlamydia trachomatis genital infections: culture or PCR?].. PubMed. 46(10). 813–8. 1 indexed citations
12.
Chabanon, G., et al.. (1997). Aspects microbiologiques des infections pulmonaires au cours de la mucoviscidose. MTP. Médecine thérapeutique pédiatrie. 3(6). 235–240. 3 indexed citations
13.
Conil, Jean‐Marie, N. Marty, G. Chabanon, et al.. (1997). Utilisation de l'amikacine en dose unique journalière chez le brûlé : étude pharmacocinétique et clinique. Médecine et Maladies Infectieuses. 27(10). 848–855. 1 indexed citations
14.
Marty, N., et al.. (1991). Adherence and hemagglutination ofCorynebacterium group D2. European Journal of Clinical Microbiology & Infectious Diseases. 10(1). 20–24. 12 indexed citations
15.
Jong, Z. de, et al.. (1988). The Frequency of Chlamydia trachomatis in Acute Epididymitis. British Journal of Urology. 62(1). 76–78. 22 indexed citations
16.
Hammami, A., et al.. (1987). [In vitro study of the effects of oxolinic acid at sub-inhibitory concentrations on the activity of hemagglutinins and adhesion to uroepithelial cells by Escherichia coli isolated from urine].. PubMed. 35(5). 545–50. 2 indexed citations
17.
Chabanon, G., et al.. (1982). [Haemagglutinins and adhesins of Escherichia coli strains isolated from urine: inhibitory effect of sub-inhibitory concentrations of tetracycline, doxycycline and minocycline. Preliminary results ].. PubMed. 30(6 Pt 2). 543–8. 4 indexed citations
18.
Icart, J, et al.. (1981). Prospective study of Epstein Barr virus (EBV) infection during pregnancy.. PubMed. 34(3). 160–3. 34 indexed citations
19.
Dalens, M., et al.. (1978). The Epstein-Barr virus (EBV) in human pathology. II. Serologic profiles of EBV infections.. PubMed. 28(1). 54–62. 4 indexed citations
20.
Chabanon, G., et al.. (1978). [Cardiopulmonary manifestations of Mycoplasma pneumoniae infections (author's transl)].. PubMed. 7(27). 2373–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E. Platsouka Breakdown of academic impact, for papers by T.G. Winstanley Breakdown of academic impact, for papers by María García-Castillo Breakdown of academic impact, for papers by P. Y. Chau Breakdown of academic impact, for papers by E. Yourassowsky Breakdown of academic impact, for papers by Peter Taylor Breakdown of academic impact, for papers by Catherine Neuwirth Breakdown of academic impact, for papers by Doroti de Oliveira Garcia Breakdown of academic impact, for papers by Pitak Santanirand Breakdown of academic impact, for papers by Sophie Vimont
Rankless by CCL
2026